26 May 2013
Keywords: cv, fourth-quarter, loss, deepens, therapeutics, drugmaker, focused
Article | 13 March 2006
CV Therapeutics, a US drugmaker focused on cardiovascular disease, says that, for the three months ended December 31, 2005, it saw a ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
13 March 2006
24 May 2013
© 2013 thepharmaletter.com